Contrast-Enhanced Whole-Heart Coronary Magnetic Resonance Angiography at 3.0-T: A Multicenter Trial

This study has been completed.
Sponsor:
Collaborators:
Fujian Medical University
Fourth Military Medical University
Huazhong University of Science and Technology
Nanjing Medical University
First Affiliated Hospital, Sun Yat-Sen University
Henan Provincial Hospital
Fudan University
Information provided by:
Capital Medical University
ClinicalTrials.gov Identifier:
NCT01024478
First received: December 1, 2009
Last updated: July 6, 2011
Last verified: December 2009
  Purpose

The multicenter study evaluates the diagnostic performance of 3.0 T contrast-enhanced whole-heart coronary MRA in patients with suspected coronary artery disease.


Condition
Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Contrast-Enhanced Whole-Heart Coronary Magnetic Resonance Angiography at 3.0-T: A Multicenter Trial

Resource links provided by NLM:


Further study details as provided by Capital Medical University:

Enrollment: 272
Study Start Date: October 2009
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Detailed Description:

This is a multicenter trial evaluated the diagnostic ability of 3.0 T contrast-enhanced whole-heart coronary MRA to detect significant coronary artery stenosis among patients with suspected CAD.

A total of 272 patients will be prospectively enrolled from 8 cities in China.

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Consecutive eligible patients scheduled to undergo conventional coronary angiography.

Criteria

Inclusion Criteria:

  • Suspected CAD, scheduled for DSA
  • Sinus rhythm

Exclusion Criteria:

  • Contraindications to MR examination: pacemaker, intraauricular implants, intracranial clips, thoracotomy, claustrophobia, orthopnea
  • Acute coronary syndrome
  • Atria fibrillation
  • Coronary stents
  • Bypass grafts
  • Renal insufficiency (estimated glomerular filtration rate assessed by creatinine clearance <60 ml/min/1.73 m2)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01024478

Locations
China, Beijing
Radiology Department of Xuanwu Hopital
Beijing, Beijing, China, 100053
Sponsors and Collaborators
Capital Medical University
Fujian Medical University
Fourth Military Medical University
Huazhong University of Science and Technology
Nanjing Medical University
First Affiliated Hospital, Sun Yat-Sen University
Henan Provincial Hospital
Fudan University
Investigators
Principal Investigator: kuncheng li, M.D. Xuanwu Hospital, Beijing
  More Information

Publications:
Responsible Party: Li,kuncheng, Radiology department of Xuanwu Hospital
ClinicalTrials.gov Identifier: NCT01024478     History of Changes
Other Study ID Numbers: CapitalMedicalU
Study First Received: December 1, 2009
Last Updated: July 6, 2011
Health Authority: China: Ministry of Health

Keywords provided by Capital Medical University:
Coronary Artery
Magnetic Resonance Angiography
Coronary Artery disease
Multicenter Trial
Cardiac MRI

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on April 17, 2014